Oct 22, 2025, 01:01 AM by User Not Found

Bio-IT World | A breakthrough in rheumatoid arthritis (RA) research may redefine how and when the autoimmune disease is diagnosed and treated. A team of researchers from the University of Colorado Anschutz., the Allen Institute for Immunology, and UC San Diego have mapped immune changes that occur years before the first swollen joint appears.

Oct 21, 2025, 08:45 AM by

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate 2,000 new compounds generated for the programme are now available from Enamine’s catalogue

Oct 21, 2025, 08:45 AM by

Biopharma PEG Scientific Inc. has expanded its portfolio of monodispersed azide-PEG derivatives to support bioconjugation, ADC linker development, and nanoparticle surface modification. The company now offers GMP-standard manufacturing from milligram to 100-kilogram scale, ensuring consistency and scalability for research and preclinical use.

Oct 21, 2025, 08:45 AM by

18 Encode AI fellows will be embedded into cutting-edge scientific labs across the UK

Oct 21, 2025, 08:45 AM by

Oct 21, 2025, 01:00 AM by User Not Found

Bio-IT World | Last month, the Longitude Prize on ALS announced the judgement panel for the prize. The panel consists of leaders and experts from neuroscience, technology, and pharmaceutical fields from around the world.

Oct 17, 2025, 05:26 AM by

FDB Announces First MCP Server for AI Clinical Decision Support and Other Medication Workflow Automation

Oct 17, 2025, 05:26 AM by

Oct 17, 2025, 05:26 AM by

Brook.ai Secures $28 Million in Series B Funding, Led by UMass Memorial Health and Morningside, to Accelerate Next Phase of Growth and Innovation in Remote Care

Oct 17, 2025, 05:26 AM by

Oct 17, 2025, 05:26 AM by

Collaboration unites elluminate platform technology and ZS RBQM expertise to offer a fully integrated, data-driven approach to risk and quality management

Oct 16, 2025, 08:31 AM by

InformedDNA and Know Your Lemons are combining their expertise in oncology, patient education, precision medicine and genetic counseling to provide personalized screening and care recommendations for those at various risks for breast cancer. The partnership extends Know Your Lemons’ mission to provide breast cancer education and guidance.

Oct 16, 2025, 08:31 AM by

Proscia®, a pathology AI company, will add AI biomarker detection for skin tissue to its Concentriq® software platform, empowering pathologists to drive efficiency and precision. Powered by Primaa, Cleo Skin* will strengthen Concentriq's lead in offering the industry’s broadest portfolio of AI solutions on a single platform. 

Oct 16, 2025, 08:31 AM by

Aylward Enterprises, a recognized leader in oral solid dose (OSD) packaging automation, highlights two complementary bulk handling solutions engineered to optimize product transfer and inspection prior to feeding: the Bulk Product Conveyor (BPC) and the BPC Sorter. Designed to seamlessly integrate with upstream feeding systems, these accessories deliver reliable product transport, chip removal, and automated inspection, helping manufacturers maintain high throughput and product quality across pharmaceutical, nutraceutical, and healthcare operations.

Oct 16, 2025, 01:01 AM by User Not Found

Bio-IT World | Last month, uniQure announced promising results from their Phase I/II study of AMT-130, the company’s gene therapy to treat Huntington’s disease. A participant pool of 29 patients in the early stages of Huntington’s disease was categorized into two groups—low-dose and high-dose—and compared to a control group of 1,600 untreated Huntington’s patients at similar disease stages.

Oct 15, 2025, 09:29 AM by

Syncell Inc. announced the deployment of its commercial Microscoop® Mint technology at two of Europe’s foremost research institutes.

Oct 15, 2025, 09:29 AM by

• Combines single-organ, multi-organ, and higher-throughput configurations within one scalable platform • Fully compatible with existing PhysioMimix accessories, validated protocols, consumables, and organ model kits for seamless workflow integration

Oct 15, 2025, 09:29 AM by

Oct 15, 2025, 09:29 AM by

Oct 15, 2025, 01:01 AM by User Not Found

Bio-IT World | Glycans, the complex sugar chains found at abnormally high levels on the surface of cancer cells, have historically been difficult to target effectively with traditional antibody therapies. One of the biggest reasons is that T cells can’t present glycans to B cells so they can make antibodies that bind strongly and stably to the target antigen.